LS Bio

Current LS Bio promotion

Use the promo code LSBIO-ELISA. Please refer to the terms & conditions below.

Save 20% on eligible LS-F ELISA kits from LSBio

Receive a 20% discount on eligible LS-F products from LSBio by using promo code LSBIO-ELISA, from October 1st until November 23, 2026

LSBio offers a broad range of ELISA and assay kits for the quantitative and qualitative detection of biological targets in research samples, including serum, plasma, cell lysates, cell culture supernatants, and tissue homogenates. Their ELISA portfolio includes traditional, cell-based, DNA-binding, phospho-specific, chemiluminescent immunoassay, and ELISA development kits, designed to support applications such as drug discovery, cancer research, immunology, toxicology, and cell signaling.

Promotion Terms and Conditions

• This promotion provides a 20% discount on eligible LSBio LS-F products only.
• Enter the promo code LSBIO-ELISA in the comment section of your webshop order or include it in your email order. The promotion cannot be applied retroactively.
  • Important: For webshop orders, enter the promo code in the comment section. Do not use the coupon code field, as it will cause an error.
• Promotion period: Promotion valid for orders received by November 23, 2026, to allow for standard 3-5 week lead times and shipment before December 31st, 2026.
• Promotional SKUs are sold as-is and are designated as non-returnable.
• Standard shipping costs still apply.
• Bio-Connect reserves the right to modify, cancel, or withdraw this promotion at any time.

LSBio provides high-quality antibodies, proteins, ELISA and assay kits to researchers worldwide. Founded in 1995, LSBio was established as a molecular pathology company with a focus on protein localization in diseased human tissues by IHC. Through the experience gained by executing thousands of IHC studies, and generating and testing many thousands of antibodies, LSBio has become a world leader in the antibody industry, with a reputation for excellence.

LSBio’s catalog includes 530,000 monoclonal and polyclonal antibodies to 19,000 targets. Antibodies are available for most species and all major research applications, such as IHC, IF, WB and FACS. Through extensive ongoing in-house testing, more than 15,000 of these antibodies have also been identified as exceptional IHC reagents and given the IHC-plus™ brand.

LSBio also offers 54,000 high quality immunoassays, including sandwich ELISA (enzyme-linked immunosorbent assay) kits and competitive EIA (enzyme immunoassay) kits, as well as cell-based and DNA-binding kits.

LSBio additionally offers 98,000 native protein extracts and engineered recombinant proteins in the form of cell lysates or highly purified reagents.

Major product lines from LS Bio

• ELISA kits
• IHC-plus™ immunohistochemistry antibodies
• PathPlus™ immunohistochemistry antibodies
• Isotype controls
• Proteins
• Primary antibodies
• Secondary antibodies

LSBio is a part of Absolute Biotech, who also has a number of other brands such as: Absolute Antibody, Nordic-MUBio, Kerafast and Everest Biotech. Bio-Connect Life Sciences supplies all brands in the Benelux. If you have any questions, please contact the helpdesk.

IHC-plus™ Immunohistochemistry Antibodies

LSBio is a leading supplier of immunohistochemistry (IHC) antibodies. Our 15,000 IHC-Plus™ antibodies have been rigorously tested to deliver optimal performance in IHC studies on formalin-fixed paraffin-embedded (FFPE) human tissues. View all here.

PathPlus™ Immunohistochemistry Antibodies

These antibodies represent the highest quality reagents available for research pathology applications. Over 2,000 antibodies were hand-selected from among thousands that were tested and identified to be the best performing reagents for immunohistochemical detection of high-value cancer and neuroscience targets in formalin-fixed paraffin-embedded human tissues. View all here.

Research Area Focuses

LSBio has focused much of its efforts on developing and testing reagents for use in the fields of oncology, neurological disorders and virology. Highly validated IHC antibodies are available to key targets associated with breast, colon, lung and prostate cancer, as well as Alzheimer’s disease.